BUILDER v.2: Improving the chemistry of a de novo design strategy
- 1 June 1995
- journal article
- research article
- Published by Springer Nature in Journal of Computer-Aided Molecular Design
- Vol. 9 (3) , 269-282
- https://doi.org/10.1007/bf00124457
Abstract
Significant improvements have been made to the de novo drug design program BUILDER. The BUILDER strategy is to find molecule templates that bind tightly to ‘hot spots’ in the target receptor, and then generate bridges to join these templates. In this paper, the bridging algorithm has been further developed to improve the chemical sense and diversity of the bridges, as well as the robustness of the technique. The improved algorithm is then applied to rebuild known bridges in methotrexate and HIV protease. Finally, the entire BUILDER approach is tested by rebuilding methotrexate de novo.Keywords
This publication has 46 references indexed in Scilit:
- Rational Design of Potent, Bioavailable, Nonpeptide Cyclic Ureas as HIV Protease InhibitorsScience, 1994
- Confirmation of usefulness of a structure construction program based on three-dimensional receptor structure for rational lead generationJournal of Medicinal Chemistry, 1993
- Structure-Based Discovery of Inhibitors of Thymidylate SynthaseScience, 1993
- Docking by least-squares fitting of molecular surface patternsJournal of Molecular Biology, 1992
- Automated site-directed drug design using molecular latticesJournal of Molecular Graphics, 1992
- Design, Activity, and 2.8 Å Crystal Structure of a C 2 Symmetric Inhibitor Complexed to HIV-1 ProteaseScience, 1990
- Molecular modeling in the design of phospholipase A2 inhibitorsJournal of Cellular Biochemistry, 1989
- The MIDAS display systemJournal of Molecular Graphics, 1988
- A geometric approach to macromolecule-ligand interactionsJournal of Molecular Biology, 1982
- The protein data bank: A computer-based archival file for macromolecular structuresJournal of Molecular Biology, 1977